Legal & General Group PLC Prothena Corp Public LTD CO Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Legal & General Group PLC holds 42,985 shares of PRTA stock, worth $580,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,985

Previous 42,985 -0.0%

Holding current value

$580,727

Previous $719,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.73 - $24.79 $24,258 - $35,945	1,450 Added 3.49%	42,985 $719,000
Q2 2024 Aug 14, 2024	BUY	$19.54 - $26.15 $51,976 - $69,559	2,660 Added 6.84%	41,535 $857,000
Q1 2024 May 14, 2024	BUY	$24.75 - $40.66 $11,830 - $19,435	478 Added 1.24%	38,875 $962,000
Q4 2023 Feb 15, 2024	SELL	$32.31 - $52.32 $3,392 - $5,493	-105 Reduced 0.27%	38,397 $1.4 Million
Q3 2023 Nov 14, 2023	BUY	$47.3 - $70.6 $35,664 - $53,232	754 Added 2.0%	38,502 $1.86 Million
Q2 2023 Aug 14, 2023	BUY	$48.26 - $78.59 $67,033 - $109,161	1,389 Added 3.82%	37,748 $2.58 Million
Q1 2023 May 15, 2023	BUY	$46.97 - $58.27 $907,695 - $1.13 Million	19,325 Added 113.45%	36,359 $1.76 Million
Q4 2022 Feb 14, 2023	BUY	$52.05 - $65.0 $5,309 - $6,630	102 Added 0.6%	17,034 $1.03 Million
Q3 2022 Nov 14, 2022	BUY	$25.16 - $60.63 $21,713 - $52,323	863 Added 5.37%	16,932 $1.03 Million
Q2 2022 Aug 22, 2022	BUY	$22.73 - $39.98 $31,685 - $55,732	1,394 Added 9.5%	16,069 $437,000
Q1 2022 May 16, 2022	BUY	$30.27 - $49.22 $6,871 - $11,172	227 Added 1.57%	14,675 $537,000
Q4 2021 Feb 14, 2022	BUY	$42.11 - $73.26 $15,412 - $26,813	366 Added 2.6%	14,448 $713,000
Q3 2021 Nov 15, 2021	BUY	$48.2 - $78.89 $293,779 - $480,834	6,095 Added 76.31%	14,082 $1 Million
Q2 2021 Aug 12, 2021	BUY	$21.63 - $57.65 $18,580 - $49,521	859 Added 12.05%	7,987 $410,000
Q1 2021 May 17, 2021	BUY	$11.0 - $28.24 $5,269 - $13,526	479 Added 7.2%	7,128 $179,000
Q3 2020 Nov 13, 2020	SELL	$9.93 - $13.47 $13,772 - $18,682	-1,387 Reduced 17.26%	6,649 $66,000
Q2 2020 Aug 14, 2020	SELL	$9.56 - $12.51 $8,202 - $10,733	-858 Reduced 9.65%	8,036 $84,000
Q1 2020 May 14, 2020	SELL	$7.54 - $15.77 $12,561 - $26,272	-1,666 Reduced 15.78%	8,894 $95,000
Q3 2019 Nov 13, 2019	BUY	$6.89 - $10.45 $18,699 - $28,361	2,714 Added 34.59%	10,560 $83,000
Q1 2019 May 15, 2019	SELL	$10.32 - $14.49 $69,814 - $98,024	-6,765 Reduced 46.3%	7,846 $95,000
Q4 2018 Feb 15, 2019	BUY	$8.73 - $13.74 $8,939 - $14,069	1,024 Added 7.54%	14,611 $151,000
Q2 2018 Aug 10, 2018	SELL	$10.99 - $44.21 $6,396 - $25,730	-582 Reduced 4.11%	13,587 $198,000
Q1 2018 May 17, 2018	SELL	$27.95 - $45.04 $73,173 - $117,914	-2,618 Reduced 15.6%	14,169 $520,000
Q4 2017 Feb 13, 2018	BUY	$35.44 - $63.76 $594,931 - $1.07 Million	16,787	16,787 $630,000

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $634M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Prothena Corp Public LTD CO Transaction History